Cardiac Sarcoidosis: Updated Insights on Epidemiology and Diagnostic Criteria.
作者信息
Santulli Gaetano
机构信息
Division of Cardiology, Department of Medicine, Wilf Family Cardiovascular Research Institute, Einstein Institute for Neuroimmunology and Inflammation (INI) and; Department of Molecular Pharmacology, Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, New York; Department of Advanced Biomedical Sciences, "Federico II" University, Naples, Italy.
出版信息
Am J Cardiol. 2023 Oct 1;204:425-427. doi: 10.1016/j.amjcard.2023.07.123. Epub 2023 Aug 19.
Abstract
摘要
相似文献
1
Cardiac Sarcoidosis: Updated Insights on Epidemiology and Diagnostic Criteria.心脏结节病：关于流行病学和诊断标准的最新见解
Am J Cardiol. 2023 Oct 1;204:425-427. doi: 10.1016/j.amjcard.2023.07.123. Epub 2023 Aug 19.
2
Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis.心脏结节病的流行病学、发病机制和诊断。
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):78-93. doi: 10.14797/mdcvj.1057. eCollection 2022.
3
Sex differences in cardiac sarcoidosis.心脏结节病中的性别差异。
Heart. 2023 Aug 24;109(18):1346-1347. doi: 10.1136/heartjnl-2023-322610.
4
Sarcoidosis-Related Cardiomyopathy: Current Knowledge, Challenges, and Future Perspectives State-of-the-Art Review.结节病相关性心肌病：现状、挑战与未来展望——综述
J Card Fail. 2022 Jan;28(1):113-132. doi: 10.1016/j.cardfail.2021.06.016. Epub 2021 Jul 11.
5
Cardiac sarcoidosis: growing evidence in risk stratification.心脏结节病：风险分层方面的证据不断增加。
Eur Heart J. 2022 Sep 21;43(36):3460-3462. doi: 10.1093/eurheartj/ehac411.
6
Debating the Definition and Incidence of Isolated Cardiac Sarcoidosis.孤立性心脏结节病的定义与发病率探讨
JACC Clin Electrophysiol. 2020 Sep;6(9):1190-1191. doi: 10.1016/j.jacep.2020.07.015.
7
Reply: Debating the Definition and Incidence of Isolated Cardiac Sarcoidosis.回复：关于孤立性心脏结节病的定义和发病率的讨论
JACC Clin Electrophysiol. 2020 Sep;6(9):1191-1192. doi: 10.1016/j.jacep.2020.07.014.
8
Cardiac sarcoidosis: from diagnosis to treatment.心肌结节病：从诊断到治疗。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):347-359. doi: 10.5507/bp.2021.057. Epub 2021 Oct 14.
9
[Inflammatory heart diseases--cardiac sarcoidosis and giant cell myocarditis].[炎症性心脏病——心脏结节病和巨细胞心肌炎]
Duodecim. 2015;131(22):2127-33.
10
Pathophysiological Gaps, Diagnostic Challenges, and Uncertainties in Cardiac Sarcoidosis.心脏结节病的病理生理差距、诊断挑战和不确定性。
J Am Heart Assoc. 2023 Mar 21;12(6):e027971. doi: 10.1161/JAHA.122.027971. Epub 2023 Mar 9.
引用本文的文献
1
A Case Report: The Utility of Multimodality Imaging in the Diagnosis of Cardiac Sarcoidosis-Has It Surpassed the Need for a Biopsy?病例报告：多模态成像在心脏结节病诊断中的应用——它是否已超越活检的必要性？
Reports (MDPI). 2025 Mar 6;8(1):28. doi: 10.3390/reports8010028.
2
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies.心脏结节病：临床见解、诊断及管理策略
Rev Cardiovasc Med. 2025 Feb 21;26(2):26605. doi: 10.31083/RCM26605. eCollection 2025 Feb.
3
Arrhythmias in Cardiac Sarcoidosis: Management and Prognostic Implications.心脏结节病中的心律失常：管理与预后意义
J Clin Med. 2024 May 28;13(11):3165. doi: 10.3390/jcm13113165.
本文引用的文献
1
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.心脏结节病治疗的当前临床实践的国际调查。
Am J Cardiol. 2023 Sep 15;203:184-192. doi: 10.1016/j.amjcard.2023.06.101. Epub 2023 Jul 25.
2
Organ involvement and assessment in sarcoidosis.结节病的器官受累和评估。
Curr Opin Pulm Med. 2023 Sep 1;29(5):485-492. doi: 10.1097/MCP.0000000000000997. Epub 2023 Jul 17.
3
Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation: The PRESTIGE Study.氟脱氧葡萄糖心肌摄取的心脏结节病免疫抑制治疗的前瞻性分析：PRESTIGE 研究。
JACC Cardiovasc Imaging. 2024 Jan;17(1):45-58. doi: 10.1016/j.jcmg.2023.05.017. Epub 2023 Jul 12.
4
Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies.心脏结节病的模仿者：未分化炎症性心肌病的基因检测
Circ Genom Precis Med. 2023 Oct;16(5):478-479. doi: 10.1161/CIRCGEN.123.004099. Epub 2023 Jul 4.
5
Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis.心脏结节病患者的临床特征和预后的性别差异。
Heart. 2023 Aug 24;109(18):1387-1393. doi: 10.1136/heartjnl-2022-322243.
6
Interleukin-1 Blockade in Cardiac Sarcoidosis: A Pilot Study.心脏结节病中白细胞介素-1阻断：一项初步研究。
Circ Arrhythm Electrophysiol. 2023 May;16(5):e011869. doi: 10.1161/CIRCEP.123.011869. Epub 2023 Apr 24.
7
New Perspective in Cardiac Sarcoidosis: The Potential Role of a Dedicated Clinic and the Importance of Collaboration Among Different Specialties.心脏结节病的新视角：专科诊所的潜在作用及不同专业间协作的重要性
Can J Cardiol. 2023 Jul;39(7):981-984. doi: 10.1016/j.cjca.2023.04.007. Epub 2023 Apr 14.
8
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.心肌结节病：表型、诊断、治疗和预后。
Eur Heart J. 2023 May 1;44(17):1495-1510. doi: 10.1093/eurheartj/ehad067.
9
Serum angiotensin-converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy.血清血管紧张素转换酶水平可提示早期肉样瘤病的诊断和免疫抑制治疗的疗效。
ESC Heart Fail. 2023 Jun;10(3):1803-1810. doi: 10.1002/ehf2.14343. Epub 2023 Mar 9.
10
The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis.心脏结节病性二尖瓣反流的机制和自然史。
Am J Cardiol. 2023 Mar 15;191:84-91. doi: 10.1016/j.amjcard.2023.01.002. Epub 2023 Jan 18.
Zotero 插件